Ki-Hong Jang, Yun-Ju Do, Tae-Sung Koo, Jun-Sub Choi, Eun Ju Song, Yeseong Hwang, Hyun Ju Bae, Ju-hee Lee, Eunhee Kim. Protective eﬀect of RIPK1-inhibitory compound in in vivo models for retinal degenerative disease. Experimental Eye Research 180 (2019):8–17
Ki-Hong Janga, Taeik Janga, Eunji Sona, Soonjin Choib, Eunhee Kim. Kinase-independent role of nuclear RIPK1 in regulating parthanatos through physical interaction with PARP1 upon oxidative stress. BBA - Molecular Cell Research 1865 (2018):132–141
Yun-Ju Do, Seo Young Yun, Min-Young Park and Eunhee Kim. The M458L missense mutation disrupts the catalytic properties of Parkin FEBS Letters. 592 (2018):78–88
Soo-Jin Kim, Eunhee Kim & Kyung-Taek Rim*. Comparative analysis of Adam33 mutations in murine lung cancer cell lines by droplet digital PCR, real-time PCR and Insight OncoTM NGS Mol Cell Toxicol. 2018 14:221-231
Changsun Yu, Bok-seok Kim, Minyoung Park, Yun-Ju Do, Young-Yun Kong and Eunhee Kim*. FAF1 mediates necrosis through JNK1-mediated mitochondrial dysfunction leading to retinal degeneration in the ganglion cell layer upon ischemic insult. Cell Communication and Signaling. 2018:16-56
Jang KH, Do YJ, Son D, Son E, Choi JS, Kim E. 2017. AIF-independent parthanatos in the pathogenesis of dry age-related macular degeneration. Cell Death Dis. 8, e2526
Yu C, Kim B, Kim E. 2016. FAF1 mediates regulated necrosis through PARP1 activation upon oxidative stress leading to dopaminergic neurodegeneration. Cell Death Differ. 23, 1873-85
Sul JW, Park MY, Shin JH, Kim YR, Yoo SE, Kong YY, Kwon KS, Lee YH, Kim E. 2013. Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration. Hum Mol Genet. 8, 1558-1573.